STAT6 Detection Service List

Service items Testing method
Affinity test Detect the affinity of binary and ternary complexes through SPR (Surface Plasmon Resonance) technology
Detection of the STAT6/CRBN ternary complex formation Using the Alphalisa technology, the binding of the drug to STAT6/CRBN to form a ternary complex was detected.
Protein Degradation Test Detect the degradation efficiency of STAT6 by the drug in A549-STAT6-HiBiT cells
Using the WB method to detect the degradation level of STAT6 by the drug in cells such as MV4-11 and Jurkat
Inhibition of signaling pathways Detection of the inhibitory effect of the drug on the phosphorylation of STAT6 induced by IL-4/IL-13
Detect the inhibition of drugs on the expression of CD23 induced by IL-13 and the release of CCL17
Selective testing Evaluation of the selectivity of the drug for STAT6 (Total STAT, pSTAT, reporter gene)
Pharmacokinetics Detect the pharmacokinetic parameters of the drug in the mice' bodies
Single-dose pharmacodynamics study Detect the degradation of STAT6 in the whole blood and spleen of mice after a single administration.
Intracellular efficacy To detect the efficacy of the drug in the MC903-induced hIL-4/hIL-4R mouse model of Alzheimer's disease (AD)
Detect the efficacy of the drug in the asthma model induced by HDM

Compound binding affinity detection to STAT6 (SPR)

Precedo
Precedo
Compound ka(1/Ms) kd(1/s) KD
AK-1690 6.05E+05 0.03029 50.1 nM
I-796 1.70E+05 0.007098 41.8 nM

Detection of STAT6-CRBN trimer complex formation (Alphalisa)

Precedo
Precedo
Bottom Top LogEC50 HillSlope EC50 (nM)
I-796 2499 19645 1.174 2.247 14.94
AK-1690 1533 164625 0.7923 1.632 6.198
Download Download

Sample Request


Registration of Human Sample Requirements


Action

Sample Request


Registration of Human Sample Requirements


Action